Literature DB >> 9508211

Progress of clinical oncology guidelines development using the Practice Guidelines Development Cycle: the role of practitioner feedback.

G P Browman1, T E Newman, E A Mohide, I D Graham, M N Levine, K I Pritchard, W K Evans, J A Maroun, D I Hodson, M S Carey, D H Cowan.   

Abstract

PURPOSE: To present an update on the development of oncology practice guidelines (PGs) using the Practice Guidelines Development Cycle (Cycle), and to present the results of surveys of oncologists on the first 10 guidelines from the Cancer Care Ontario Practice Guidelines Initiative.
METHODS: Practitioners' opinions about guidelines in development were sought using a mail survey method with systematic follow-up. Practitioners were identified by cancer center representatives. Survey packages included evidence-based recommendations (EBRs) and a one-page, nine-item feedback questionnaire. Data were collected between February 1995 and February 1996.
RESULTS: Nine hundred fourteen surveys that pertained to 10 guidelines were mailed to 423 practitioners in Ontario. Practitioners included 112 medical oncologists/hematologists, 34 radiation oncologists, 195 surgeons, and 82 practitioners from other medical specialities. One hundred practitioners were located in cancer centers and 323 had community-based practices. The overall response rate by practitioner was 72% and by survey questionnaire, 70%. For the five questionnaire items that assessed guideline quality, approval ratings ranged from 86% to 92%. For the 10 recommendations, 77% ( 63% to 82%) of respondents agreed that the EBR could be approved as a PG. Response and approval rates were consistent across medical specialities and locations of practice.
CONCLUSION: The process of obtaining practitioner feedback in the development of PGs is both feasible and useful. The high response rates to the survey indicate that it is possible to obtain broad participation in evidence-based guidelines development throughout Ontario. The changes made to the EBRs in response to feedback suggest that practitioners' opinions can be valuable in shaping evidence-based guidelines.

Entities:  

Mesh:

Year:  1998        PMID: 9508211     DOI: 10.1200/JCO.1998.16.3.1226

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  44 in total

1.  Invasive mediastinal staging of non-small-cell lung cancer: a clinical practice guideline.

Authors:  G E Darling; A J Dickie; R A Malthaner; E B Kennedy; R Tey
Journal:  Curr Oncol       Date:  2011-12       Impact factor: 3.677

2.  Safe handling of parenteral cytotoxics: recommendations for ontario.

Authors:  Esther Green; Mary Johnston; Maureen Trudeau; Lisa Schwartz; Susan Poirier; Gail Macartney; Deborah Milliken
Journal:  J Oncol Pract       Date:  2009-09       Impact factor: 3.840

Review 3.  The interface of primary and oncology specialty care: from symptoms to diagnosis.

Authors:  Larissa Nekhlyudov; Steven Latosinsky
Journal:  J Natl Cancer Inst Monogr       Date:  2010

4.  Health care use and risk of ovarian cancer: is there a link?

Authors:  Michael Fung-Kee-Fung; Melissa Brouwers; Thomas K Oliver; Barry Rosen
Journal:  CMAJ       Date:  2007-03-27       Impact factor: 8.262

5.  National Collaborative to Improve Oncology Practice: The National Cancer Institute Community Cancer Centers Program Quality Oncology Practice Initiative Experience.

Authors:  Robert D Siegel; Steven B Clauser; Jean M Lynn
Journal:  J Oncol Pract       Date:  2009-11       Impact factor: 3.840

6.  Optimal systemic therapy for early breast cancer in women: a clinical practice guideline.

Authors:  A Eisen; G G Fletcher; S Gandhi; M Mates; O C Freedman; S F Dent; M E Trudeau
Journal:  Curr Oncol       Date:  2015-03       Impact factor: 3.677

7.  Locoregional therapy of locally advanced breast cancer: a clinical practice guideline.

Authors:  M Brackstone; G G Fletcher; I S Dayes; Y Madarnas; S K SenGupta; S Verma
Journal:  Curr Oncol       Date:  2015-03       Impact factor: 3.677

8.  Primary excision margins, sentinel lymph node biopsy, and completion lymph node dissection in cutaneous melanoma: a clinical practice guideline.

Authors:  F C Wright; L H Souter; S Kellett; A Easson; C Murray; J Toye; D McCready; C Nessim; D Ghazarian; N J Look Hong; S Johnson; D P Goldstein; T Petrella
Journal:  Curr Oncol       Date:  2019-08-01       Impact factor: 3.677

9.  Clinicians' evaluations of, endorsements of, and intentions to use practice guidelines change over time: a retrospective analysis from an organized guideline program.

Authors:  Melissa Brouwers; Steven Hanna; Mona Abdel-Motagally; Jennifer Yee
Journal:  Implement Sci       Date:  2009-06-28       Impact factor: 7.327

10.  Clinician-patient communication: evidence-based recommendations to guide practice in cancer.

Authors:  G Rodin; C Zimmermann; C Mayer; D Howell; M Katz; J Sussman; J A Mackay; M Brouwers
Journal:  Curr Oncol       Date:  2009-12       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.